Electrochemical Valence‐Regulated Biomimetic Nanozymes for Breast Cancer Metabolism Inhibition and Potentiated Catalytic Immunotherapy
Exploration · 2026-10 · 6 (5)
DOI: 10.1002/exp2.70224 ↗Kurz gefasst
Fachartikel in der Zeitschrift Exploration, online erschienen am 17.09.2026. Verfasst von You Pan und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery The Second Affiliated Hospital of Guangxi Medical University Nanning China. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Guangxi Province, National Natural Science Foundation of China, Natural Science Foundation of Hubei Province.
Abstract (Originalsprache)
Manganese oxide (MnO x ) nanozymes have garnered significant attention for their ability to respond to the tumor microenvironment (TME) and stimulator of interferon genes (STING) pathway activation. However, they often suffer from a weak direct tumor‐killing capacity due to low enzymatic activity and from attenuated anti‐tumor immunity resulting from STING activation‐induced excessive programmed death‐ligand 1 (PD‐L1) expression. In this study, we fabricated MnO x nanozymes with precisely controllable valence states via electrochemical valence regulation to modulate their oxidase‐like activity. Notably, M‐MnOx, with a bulk Mn oxidation state of +3.62, a near‐surface Mn oxidation state of approximately +3.23, 19.1% oxygen vacancies, and a reduced Mn−O coordination number of 4.7, exhibited the highest oxidase‐like activity and was therefore selected for cancer therapy. This nanozyme was subsequently wrapped with a T lymphocyte membrane (TCM) to form biomimetic nanozymes (TMO). TMO efficiently targets tumors and induces immunogenic cell death via oxidase catalytic therapy, while also activating the cGAS‐STING pathway and T cells for tumor killing. Furthermore, TMO competitively binds to tumor cell highly expressed PD‐L1 to alleviate T cell immune suppression. Consequently, TMO demonstrates excellent tumor‐killing efficacy and inhibits recurrence in vivo. This research offers a new perspective for the construction of manganese‐based nanomaterials.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Breast Surgery The Second Affiliated Hospital of Guangxi Medical University Nanning China.
- Department of Radiology Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan China.
- Research Centers of Nanomedicine Technology & Clinical Medicine The Second Affiliated Hospital of Guangxi Medical University Nanning China.
- CAS Engineering Laboratory For Nanozyme State Key Laboratory of Biomacromolecules Institute of Biophysics Chinese Academy of Sciences Beijing China.
- Cancer Center Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan China.
- Department of Biomedical Engineering Columbia University New York City New York USA.
Förderung
- Natural Science Foundation of Guangxi Province
- National Natural Science Foundation of China
- Natural Science Foundation of Hubei Province
Zitieren
APA
Pan, Y., Cai, W., Suo, M., Meng, X., Ye, S., Tan, Y., Wei, X., Yang, M., Qi, P., Yu, Z., Fan, K., & Ning, S. (2026). Electrochemical Valence‐Regulated Biomimetic Nanozymes for Breast Cancer Metabolism Inhibition and Potentiated Catalytic Immunotherapy. Exploration, 6(5). https://doi.org/10.1002/exp2.70224
Vancouver
Pan Y, Cai W, Suo M, Meng X, Ye S, Tan Y, et al. Electrochemical Valence‐Regulated Biomimetic Nanozymes for Breast Cancer Metabolism Inhibition and Potentiated Catalytic Immunotherapy. Exploration. 2026;6(5). doi:10.1002/exp2.70224
BibTeX
@article{Pan2026,
author = {Pan, You and Cai, Wei and Suo, Meng and Meng, Xiangqin and Ye, Shengxin and Tan, Yuping and Wei, Xianqing and Yang, Mingpu and Qi, Pengyuan and Yu, Zihang and Fan, Kelong and Ning, Shipeng},
title = {Electrochemical Valence‐Regulated Biomimetic Nanozymes for Breast Cancer Metabolism Inhibition and Potentiated Catalytic Immunotherapy},
journal = {Exploration},
year = {2026},
volume = {6},
number = {5},
doi = {10.1002/exp2.70224}
}
EUVIMED